Skip to Content

par 545 (Ranitidine Hydrochloride 300 mg)

Pill with imprint par 545 is Yellow, Elliptical / Oval and has been identified as Ranitidine Hydrochloride 300 mg. It is supplied by Par Pharmaceutical Inc..

Ranitidine is used in the treatment of duodenal ulcer; gerd; erosive esophagitis; cutaneous mastocytosis; duodenal ulcer prophylaxis and belongs to the drug class H2 antagonists. There is no proven risk in humans during pregnancy. Ranitidine 300 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for par 545

Ranitidine hydrochloride 300 mg par 545 Front
Ranitidine hydrochloride 300 mg par 545 Back
Ranitidine hydrochloride 300 mg par 545
Ranitidine hydrochloride 300 mg par 545

Ranitidine Hydrochloride

Imprint
par 545
Strength
300 mg
Color
Yellow
Size
14.00 mm
Shape
Elliptical / Oval
Availability
Rx and/or OTC
Drug Class
H2 antagonists
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Par Pharmaceutical Inc.
National Drug Code (NDC)
49884-0545
Inactive Ingredients
FD&C Yellow No. 6, lactose monohydrate, magnesium stearate, microcrystalline cellulose, titanium dioxide, triethyl citrate, ferric oxide yellow, corn starch

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.